Is this stock market theme a big opportunity or a bubble?
Ailsa Craig, manager of International Biotechnology Trust, discusses weight-loss drugs, themes she’s favouring in biotech, and why she’s optimistic the sector will bounce back from its worst-ever bear market.
9th May 2024 08:55
You can also listen on: Spotify, Apple Podcasts, Amazon, Google Podcasts
A new generation of weight-loss drugs have proved appetising to investors, with the two companies currently dominating the market enjoying strong share price gains over the past few years. Other firms are also poised to join the trend, which is expected to expand significantly by 2030.
However, does the hype risk creating an obesity-drug bubble? Joining Kyle to answer that question and discuss the outlook for the theme is Ailsa Craig, manager of International Biotechnology Ord (LSE:IBT) Trust. Ailsa also names themes she’s favouring in biotech and explains why she’s optimistic the sector will bounce back from its worst-ever bear market.
- Invest with ii: SIPP Account | Stocks & Shares ISA | See all Investment Accounts
On The Money is an interactive investor (ii) podcast. For more investment news and ideas, visit https://www.ii.co.uk/stock-market-news.
Kyle Caldwell is collectives editor at interactive investor.
These articles are provided for information purposes only. Occasionally, an opinion about whether to buy or sell a specific investment may be provided by third parties. The content is not intended to be a personal recommendation to buy or sell any financial instrument or product, or to adopt any investment strategy as it is not provided based on an assessment of your investing knowledge and experience, your financial situation or your investment objectives. The value of your investments, and the income derived from them, may go down as well as up. You may not get back all the money that you invest. The investments referred to in this article may not be suitable for all investors, and if in doubt, an investor should seek advice from a qualified investment adviser.
Full performance can be found on the company or index summary page on the interactive investor website. Simply click on the company's or index name highlighted in the article.